非酒精性脂肪性肝炎
医学
肝病学
非酒精性脂肪肝
行动号召
家庭医学
临床试验
政治学
内科学
脂肪肝
疾病
业务
营销
作者
Fasiha Kanwal,Jay H. Shubrook,Zobair M. Younossi,Yamini Natarajan,Elisabetta Bugianesi,Mary Rinella,Stephen A. Harrison,Christos S. Mantzoros,Kim Pfotenhauer,Samuel Klein,Robert H. Eckel,Davida F. Kruger,Hashem B. El‐Serag,Kenneth Cusi
出处
期刊:Gastroenterology
[Elsevier]
日期:2021-09-01
卷期号:161 (3): 1030-1042.e8
被引量:58
标识
DOI:10.1053/j.gastro.2021.04.074
摘要
Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are common conditions with a rising burden. Yet there are significant management gaps between clinical guidelines and practice in patients with NAFLD and NASH. Further, there is no single global guiding strategy for the management of NAFLD and NASH. The American Gastroenterological Association, in collaboration with 7 professional associations, convened an international conference comprising 32 experts in gastroenterology, hepatology, endocrinology, and primary care providers from the United States, Europe, Asia, and Australia. Conference content was informed by the results of a national NASH Needs Assessment Survey. The participants reviewed and discussed published literature on global burden, screening, risk stratification, diagnosis, and management of individuals with NAFLD, including those with NASH. Participants identified promising approaches for clinical practice and prepared a comprehensive, unified strategy for primary care providers and relevant specialists encompassing the full spectrum of NAFLD/NASH care. They also identified specific high-yield targets for clinical research and called for a unified, international public health response to NAFLD and NASH.
科研通智能强力驱动
Strongly Powered by AbleSci AI